Tcrcure Biopharma Ltd.

This early-stage study is testing a new CAR-T cell therapy called TC-D101 for people with advanced small cell lung cancer that has returned or stopped responding to standard treatments. The study will enroll 24 patients to determine the safest dose and see if the therapy shows ea…

This early-stage trial is testing a new type of cell therapy for people with advanced solid tumors that have a specific protein called ALPP. The therapy involves collecting a patient's own immune cells, modifying them in a lab to better target the cancer, and then infusing them b…